Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.

Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.

Item
http://www.wikidata.org/entity/Q43053307
In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model.Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?Ewing sarcoma: clinical state-of-the-art.The Role of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Assessing the Response to Neoadjuvant Treatment in Patients with Osteosarcoma.Tumor-to-background ratio to predict response to chemotherapy of osteosarcoma better than standard uptake values.Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome.Statistical assessment of treatment response in a cancer patient based on pre-therapy and post-therapy FDG-PET scans.Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma.18F-FDG PET/CT as an Indicator of Survival in Ewing Sarcoma of Bone.Tumour response of osteosarcoma to neoadjuvant chemotherapy evaluated by magnetic resonance imaging as prognostic factor for outcome.Atypical growth on MRI in a case of Ewing's sarcoma despite lower SUV on PET.Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma.Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib.The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence.Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CT.Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma.
P2860

Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.

Item
http://www.wikidata.org/entity/Q43053307
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Assessment of histological res ...... d standardized MRI parameters.
@en
Assessment of histological res ...... d standardized MRI parameters.
@nl
type
label
Assessment of histological res ...... d standardized MRI parameters.
@en
Assessment of histological res ...... d standardized MRI parameters.
@nl
prefLabel
Assessment of histological res ...... d standardized MRI parameters.
@en
Assessment of histological res ...... d standardized MRI parameters.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Assessment of histological res ...... nd standardized MRI parameters
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P698